Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology - A present status Article Swipe
Prashant Mehta
,
Vineet Talwar
,
Ankur Bahl
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.25259/ijmio-2-2019
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.25259/ijmio-2-2019
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.25259/ijmio-2-2019
- OA Status
- hybrid
- References
- 32
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2916778038
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2916778038Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.25259/ijmio-2-2019Digital Object Identifier
- Title
-
Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology - A present statusWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-02-16Full publication date if available
- Authors
-
Prashant Mehta, Vineet Talwar, Ankur BahlList of authors in order
- Landing page
-
https://doi.org/10.25259/ijmio-2-2019Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.25259/ijmio-2-2019Direct OA link when available
- Concepts
-
Clinical Oncology, Internal medicine, Medicine, Immunotherapy, Oncology, Surgical oncology, Gynecologic oncology, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
32Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2916778038 |
|---|---|
| doi | https://doi.org/10.25259/ijmio-2-2019 |
| ids.doi | https://doi.org/10.25259/ijmio-2-2019 |
| ids.mag | 2916778038 |
| ids.openalex | https://openalex.org/W2916778038 |
| fwci | 0.0 |
| type | article |
| title | Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology - A present status |
| biblio.issue | |
| biblio.volume | 4 |
| biblio.last_page | 5 |
| biblio.first_page | 3 |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T11491 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | CAR-T cell therapy research |
| topics[2].id | https://openalex.org/T10580 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9972000122070312 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immunotherapy and Immune Responses |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776598537 |
| concepts[0].level | 3 |
| concepts[0].score | 0.5590636730194092 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1812651 |
| concepts[0].display_name | Clinical Oncology |
| concepts[1].id | https://openalex.org/C126322002 |
| concepts[1].level | 1 |
| concepts[1].score | 0.5293700695037842 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[1].display_name | Internal medicine |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5170127153396606 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2777701055 |
| concepts[3].level | 3 |
| concepts[3].score | 0.48879382014274597 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[3].display_name | Immunotherapy |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.48800674080848694 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C2780140570 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4613269865512848 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3545481 |
| concepts[5].display_name | Surgical oncology |
| concepts[6].id | https://openalex.org/C2780435969 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4302602708339691 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q5625186 |
| concepts[6].display_name | Gynecologic oncology |
| concepts[7].id | https://openalex.org/C121608353 |
| concepts[7].level | 2 |
| concepts[7].score | 0.1579032838344574 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[7].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/clinical-oncology |
| keywords[0].score | 0.5590636730194092 |
| keywords[0].display_name | Clinical Oncology |
| keywords[1].id | https://openalex.org/keywords/internal-medicine |
| keywords[1].score | 0.5293700695037842 |
| keywords[1].display_name | Internal medicine |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.5170127153396606 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/immunotherapy |
| keywords[3].score | 0.48879382014274597 |
| keywords[3].display_name | Immunotherapy |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.48800674080848694 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/surgical-oncology |
| keywords[5].score | 0.4613269865512848 |
| keywords[5].display_name | Surgical oncology |
| keywords[6].id | https://openalex.org/keywords/gynecologic-oncology |
| keywords[6].score | 0.4302602708339691 |
| keywords[6].display_name | Gynecologic oncology |
| keywords[7].id | https://openalex.org/keywords/cancer |
| keywords[7].score | 0.1579032838344574 |
| keywords[7].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.25259/ijmio-2-2019 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210192973 |
| locations[0].source.issn | 2456-3994, 2836-3779 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2456-3994 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | International Journal of Molecular and Immuno Oncology |
| locations[0].source.host_organization | https://openalex.org/P4323830092 |
| locations[0].source.host_organization_name | Scientific Scholar |
| locations[0].source.host_organization_lineage | https://openalex.org/P4323830092 |
| locations[0].license | cc-by-nc-sa |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-sa |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Molecular and Immuno Oncology |
| locations[0].landing_page_url | https://doi.org/10.25259/ijmio-2-2019 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5101955205 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8151-4331 |
| authorships[0].author.display_name | Prashant Mehta |
| authorships[0].countries | IN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210092995 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Rajiv Gandhi Cancer Institute, Delhi, India |
| authorships[0].institutions[0].id | https://openalex.org/I4210092995 |
| authorships[0].institutions[0].ror | https://ror.org/00e7cvg05 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210092995 |
| authorships[0].institutions[0].country_code | IN |
| authorships[0].institutions[0].display_name | Rajiv Gandhi Cancer Institute and Research Centre |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Prashant Mehta |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Medical Oncology, Rajiv Gandhi Cancer Institute, Delhi, India |
| authorships[1].author.id | https://openalex.org/A5083744967 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9149-6969 |
| authorships[1].author.display_name | Vineet Talwar |
| authorships[1].countries | IN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210092995 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Rajiv Gandhi Cancer Institute, Delhi, India |
| authorships[1].institutions[0].id | https://openalex.org/I4210092995 |
| authorships[1].institutions[0].ror | https://ror.org/00e7cvg05 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210092995 |
| authorships[1].institutions[0].country_code | IN |
| authorships[1].institutions[0].display_name | Rajiv Gandhi Cancer Institute and Research Centre |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Vineet Talwar |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Medical Oncology, Rajiv Gandhi Cancer Institute, Delhi, India |
| authorships[2].author.id | https://openalex.org/A5102771876 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0057-5368 |
| authorships[2].author.display_name | Ankur Bahl |
| authorships[2].countries | IN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210092995 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Rajiv Gandhi Cancer Institute, Delhi, India |
| authorships[2].institutions[0].id | https://openalex.org/I4210092995 |
| authorships[2].institutions[0].ror | https://ror.org/00e7cvg05 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210092995 |
| authorships[2].institutions[0].country_code | IN |
| authorships[2].institutions[0].display_name | Rajiv Gandhi Cancer Institute and Research Centre |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Ankur Bahl |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Medical Oncology, Rajiv Gandhi Cancer Institute, Delhi, India |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.25259/ijmio-2-2019 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology - A present status |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W2729322685, https://openalex.org/W1900195649, https://openalex.org/W2622821298, https://openalex.org/W2739012570, https://openalex.org/W4249313752, https://openalex.org/W2890274714, https://openalex.org/W4253187863, https://openalex.org/W357581974, https://openalex.org/W173919872, https://openalex.org/W1966874101 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.25259/ijmio-2-2019 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210192973 |
| best_oa_location.source.issn | 2456-3994, 2836-3779 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2456-3994 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | International Journal of Molecular and Immuno Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4323830092 |
| best_oa_location.source.host_organization_name | Scientific Scholar |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4323830092 |
| best_oa_location.license | cc-by-nc-sa |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-sa |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Molecular and Immuno Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.25259/ijmio-2-2019 |
| primary_location.id | doi:10.25259/ijmio-2-2019 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210192973 |
| primary_location.source.issn | 2456-3994, 2836-3779 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2456-3994 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | International Journal of Molecular and Immuno Oncology |
| primary_location.source.host_organization | https://openalex.org/P4323830092 |
| primary_location.source.host_organization_name | Scientific Scholar |
| primary_location.source.host_organization_lineage | https://openalex.org/P4323830092 |
| primary_location.license | cc-by-nc-sa |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-sa |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Molecular and Immuno Oncology |
| primary_location.landing_page_url | https://doi.org/10.25259/ijmio-2-2019 |
| publication_date | 2019-02-16 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2767646876, https://openalex.org/W2198093519, https://openalex.org/W2527905628, https://openalex.org/W2156353875, https://openalex.org/W2104347254, https://openalex.org/W2796582438, https://openalex.org/W2892640821, https://openalex.org/W2900082702, https://openalex.org/W2635951006, https://openalex.org/W2797675588, https://openalex.org/W2797855256, https://openalex.org/W2768158636, https://openalex.org/W2559382297, https://openalex.org/W2383119765, https://openalex.org/W2793364080, https://openalex.org/W2598203798, https://openalex.org/W2763064222, https://openalex.org/W2606367731, https://openalex.org/W1940241680, https://openalex.org/W2810990959, https://openalex.org/W2905022081, https://openalex.org/W2886119834, https://openalex.org/W2794690279, https://openalex.org/W2810134512, https://openalex.org/W2791442381, https://openalex.org/W2792937256, https://openalex.org/W2529484692, https://openalex.org/W2604629435, https://openalex.org/W2495091068, https://openalex.org/W2883447733, https://openalex.org/W2789502254, https://openalex.org/W2767215526 |
| referenced_works_count | 32 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 3 |
| citation_normalized_percentile.value | 0.01826509 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |